Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Malm

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Molecular Immunology|August 31, 2016
Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 proteinMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Antiviral Research|June 24, 2018
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4<sup>+</sup> T lymphocytes with cytotoxic potentialSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Vaccine|February 10, 2007
GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge modelMaria Malm, Rein Sikut, Kai Krohn, et al.
Viral Immunology|November 16, 2018
Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse SeraMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Frontiers in Microbiology|October 19, 2016
Norovirus-Specific Memory T Cell Responses in Adult Human DonorsMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Journal of Medical Virology|July 20, 2016
Rotavirus vaccination and infection induce VP6-specific IgA responsesSuvi Lappalainen, Vesna Blazevic, Maria Malm, et al.
The Journal of Infectious Diseases|June 28, 2014
High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in childrenMaria Malm, Hanni Uusi-Kerttula, Timo Vesikari, et al.
Human Vaccines & Immunotherapeutics|October 16, 2015
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccineVesna Blazevic, Maria Malm, Daisuke Arinobu, et al.
Vaccine|December 17, 2017
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypesMaria Malm, Kirsi Tamminen, Suvi Heinimäki, et al.
Journal of Immunology Research|October 1, 2016
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like ParticlesMaria Malm, Kirsi Tamminen, Suvi Lappalainen, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Molecular Immunology|August 31, 2016
Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 proteinMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Antiviral Research|June 24, 2018
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4<sup>+</sup> T lymphocytes with cytotoxic potentialSuvi Heinimäki, Maria Malm, Timo Vesikari, et al.
Vaccine|February 10, 2007
GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge modelMaria Malm, Rein Sikut, Kai Krohn, et al.
Viral Immunology|November 16, 2018
Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse SeraMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Frontiers in Microbiology|October 19, 2016
Norovirus-Specific Memory T Cell Responses in Adult Human DonorsMaria Malm, Kirsi Tamminen, Timo Vesikari, et al.
Journal of Medical Virology|July 20, 2016
Rotavirus vaccination and infection induce VP6-specific IgA responsesSuvi Lappalainen, Vesna Blazevic, Maria Malm, et al.
The Journal of Infectious Diseases|June 28, 2014
High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in childrenMaria Malm, Hanni Uusi-Kerttula, Timo Vesikari, et al.
Human Vaccines & Immunotherapeutics|October 16, 2015
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccineVesna Blazevic, Maria Malm, Daisuke Arinobu, et al.
Vaccine|December 17, 2017
Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypesMaria Malm, Kirsi Tamminen, Suvi Heinimäki, et al.
Journal of Immunology Research|October 1, 2016
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like ParticlesMaria Malm, Kirsi Tamminen, Suvi Lappalainen, et al.
Pageof 7